194 related articles for article (PubMed ID: 28760865)
1. Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development.
Clements R; Turk R; Campbell KP; Wright KM
J Neurosci; 2017 Aug; 37(35):8559-8574. PubMed ID: 28760865
[TBL] [Abstract][Full Text] [Related]
2. Laminin β2 Chain Regulates Retinal Progenitor Cell Mitotic Spindle Orientation via Dystroglycan.
Serjanov D; Bachay G; Hunter DD; Brunken WJ
J Neurosci; 2018 Jun; 38(26):5996-6010. PubMed ID: 29853630
[TBL] [Abstract][Full Text] [Related]
3. The many roles of dystroglycan in nervous system development and function: Dystroglycan and neural circuit development: Dystroglycan and neural circuit development.
Jahncke JN; Wright KM
Dev Dyn; 2023 Jan; 252(1):61-80. PubMed ID: 35770940
[TBL] [Abstract][Full Text] [Related]
4. Retinal ganglion cell axon sorting at the optic chiasm requires dystroglycan.
Clements R; Wright KM
Dev Biol; 2018 Oct; 442(2):210-219. PubMed ID: 30149005
[TBL] [Abstract][Full Text] [Related]
5. Dystroglycan regulates structure, proliferation and differentiation of neuroepithelial cells in the developing vertebrate CNS.
Schröder JE; Tegeler MR; Grosshans U; Porten E; Blank M; Lee J; Esapa C; Blake DJ; Kröger S
Dev Biol; 2007 Jul; 307(1):62-78. PubMed ID: 17512925
[TBL] [Abstract][Full Text] [Related]
6. Dystroglycan is a scaffold for extracellular axon guidance decisions.
Lindenmaier LB; Parmentier N; Guo C; Tissir F; Wright KM
Elife; 2019 Feb; 8():. PubMed ID: 30758284
[TBL] [Abstract][Full Text] [Related]
7. Retinal ectopias and mechanically weakened basement membrane in a mouse model of muscle-eye-brain (MEB) disease congenital muscular dystrophy.
Hu H; Candiello J; Zhang P; Ball SL; Cameron DA; Halfter W
Mol Vis; 2010 Jul; 16():1415-28. PubMed ID: 20680099
[TBL] [Abstract][Full Text] [Related]
8. Glial scaffold required for cerebellar granule cell migration is dependent on dystroglycan function as a receptor for basement membrane proteins.
Nguyen H; Ostendorf AP; Satz JS; Westra S; Ross-Barta SE; Campbell KP; Moore SA
Acta Neuropathol Commun; 2013 Sep; 1():58. PubMed ID: 24252195
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory CCK+ basket synapse defects in mouse models of dystroglycanopathy.
Jahncke JN; Miller DS; Krush M; Schnell E; Wright KM
Elife; 2024 Jan; 12():. PubMed ID: 38179984
[TBL] [Abstract][Full Text] [Related]
10. Dystroglycan organizes axon guidance cue localization and axonal pathfinding.
Wright KM; Lyon KA; Leung H; Leahy DJ; Ma L; Ginty DD
Neuron; 2012 Dec; 76(5):931-44. PubMed ID: 23217742
[TBL] [Abstract][Full Text] [Related]
11. TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy.
Larson AA; Baker PR; Milev MP; Press CA; Sokol RJ; Cox MO; Lekostaj JK; Stence AA; Bossler AD; Mueller JM; Prematilake K; Tadjo TF; Williams CA; Sacher M; Moore SA
Skelet Muscle; 2018 May; 8(1):17. PubMed ID: 29855340
[TBL] [Abstract][Full Text] [Related]
12.
Zhou M; Wang H; Ren H; Jiang R; Zhang C; Wu X; Xu G
Cell Biosci; 2017; 7():18. PubMed ID: 28428837
[TBL] [Abstract][Full Text] [Related]
13. Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain.
Satz JS; Ostendorf AP; Hou S; Turner A; Kusano H; Lee JC; Turk R; Nguyen H; Ross-Barta SE; Westra S; Hoshi T; Moore SA; Campbell KP
J Neurosci; 2010 Oct; 30(43):14560-72. PubMed ID: 20980614
[TBL] [Abstract][Full Text] [Related]
14. Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation.
Sato S; Omori Y; Katoh K; Kondo M; Kanagawa M; Miyata K; Funabiki K; Koyasu T; Kajimura N; Miyoshi T; Sawai H; Kobayashi K; Tani A; Toda T; Usukura J; Tano Y; Fujikado T; Furukawa T
Nat Neurosci; 2008 Aug; 11(8):923-31. PubMed ID: 18641643
[TBL] [Abstract][Full Text] [Related]
15. Reactive gliosis of astrocytes and Müller glial cells in retina of POMGnT1-deficient mice.
Takahashi H; Kanesaki H; Igarashi T; Kameya S; Yamaki K; Mizota A; Kudo A; Miyagoe-Suzuki Y; Takeda S; Takahashi H
Mol Cell Neurosci; 2011 Jun; 47(2):119-30. PubMed ID: 21447391
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy.
Zhang P; Yang Y; Candiello J; Thorn TL; Gray N; Halfter WM; Hu H
Matrix Biol; 2013 Apr; 32(3-4):196-207. PubMed ID: 23454088
[TBL] [Abstract][Full Text] [Related]
17. Removal of pomt1 in zebrafish leads to loss of α-dystroglycan glycosylation and dystroglycanopathy phenotypes.
Karas BF; Terez KR; Mowla S; Battula N; Flannery KP; Gural BM; Aboussleman G; Mubin N; Manzini MC
Hum Mol Genet; 2024 Apr; 33(8):709-723. PubMed ID: 38272461
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic aspects of the formation of α-dystroglycan and therapeutic research for the treatment of α-dystroglycanopathy: A review.
Taniguchi-Ikeda M; Morioka I; Iijima K; Toda T
Mol Aspects Med; 2016 Oct; 51():115-24. PubMed ID: 27421908
[TBL] [Abstract][Full Text] [Related]
19. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
Moore SA; Saito F; Chen J; Michele DE; Henry MD; Messing A; Cohn RD; Ross-Barta SE; Westra S; Williamson RA; Hoshi T; Campbell KP
Nature; 2002 Jul; 418(6896):422-5. PubMed ID: 12140559
[TBL] [Abstract][Full Text] [Related]
20. Ectopic clustering of Cajal-Retzius and subplate cells is an initial pathological feature in Pomgnt2-knockout mice, a model of dystroglycanopathy.
Nakagawa N; Yagi H; Kato K; Takematsu H; Oka S
Sci Rep; 2015 Jun; 5():11163. PubMed ID: 26060116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
